- 2016
-
Press releases - 11.04.2016
An invisible system to rescue the heart
Heart failure affects over one million people in France. Although the blood system is the first to have been explored for the purpose of improving heart function, a study by Inserm has revealed the potential of a secondary system that had previously received scant attention. The researchers[1] analysed the heart lymphatic system in an animal model. They showed that this system was highly impaired following a myocardial infarction. Using a biotherapy based on the injection of innovative microparticles, they succeeded in regenerating lymphatic vessels in a targeted manner. This treatment promotes lymphatic drainage, thus limiting post-infarct oedema and inflammation. Heart function is thereby improved.
-
Press releases - 11.04.2016
MSDAVENIR and Inserm sign a strategic framework agreement
Cyril Schiever, Chairman of the Board of MSDAVENIR, Professor Yves Lévy, Chairman and CEO of Inserm and Pascale Augé, President of the Executive Board of Inserm Transfert, today signed a strategic framework agreement to support French medical research.This event took place under the patronage and in the presence of Marisol Touraine, French Minister for Social Affairs and Health, and Thierry Mandon, Secretary of State for Higher Education and Research.
-
Press releases - 08.04.2016
An effective drug for myoclonus-dystonia, a rare disease of the nervous system
A team coordinated by Prof. Emmanuel Flamand-Roze from Pitié-Salpêtrière Hospital, AP-HP, has tested, at the clinical investigation centre of the Brain and Spine Institute (Inserm /CNRS/UPMC) , the efficacy of zonisamide, a drug currently used to treat certain forms of epilepsy, in 23 patients with a rare disease of the nervous system, myoclonus-dystonia. The promising results from this trial, which was funded by AP-HP (the Paris Public Hospitals), are the subject of a publication in the journal Neurology on 6 April 2016.
-
Press releases - 05.04.2016
Jumping genes: all guilty?
Transposable elements, also known as “jumping genes” are DNA fragments that can move or copy themselves from one location to another on the chromosomes. They have invaded the genomes of most living organisms, from bacteria to humans, via the plants. When they jump, they bring about complex modifications in genes near which or in which they insert themselves, and can thereby alter or abolish their function. This phenomenon contributes to the evolution and adaptation of species.
-
What's on? - 04.04.2016
Thursday 7 April 2016: World Health Day
Celebrated on 7 April next, World Health Day will be devoted to diabetes this year. The incidence of diabetes is growing rapidly worldwide, and more particularly in developing countries. In 2014, 8.5% of the adult population was diabetic.[1] World Health Day is an opportunity to raise awareness among the public authorities, the health authorities and […]
-
Press releases - 29.03.2016
Saturday 2 April 2016: World Autism Awareness Day
Next Saturday, 2 April, is World Autism Awareness Day. This event is aimed at reminding the general public, professionals and politicians of the need to improve the quality of life of people suffering from this disorder.
-
What's on? - 29.03.2016
Saturday 2 April 2016: World Autism Awareness Day
Next Saturday, 2 April, is World Autism Awareness Day. This event is aimed at reminding the general public, professionals and politicians of the need to improve the quality of life of people suffering from this disorder. Autism is a pervasive developmental disorder characterised by impaired social interactions and verbal and non-verbal communication, and by repetitive […]
-
Press releases - 29.03.2016
Dassault Systèmes and Inserm Announce Joint Agreement to Decipher Disease Complexity and Accelerate Clinical Research
Next Generation Scientific Innovation with the 3DEXPERIENCE Platform and Strategic Collaboration to Advance Programs in Aging, Cancer, Genomics and Microbiota
-
Press releases - 24.03.2016
Isolated case of bovine spongiform encephalopathy (BSE) in France
This Thursday, 24 March, the Ministry of Agriculture confirmed an isolated case of bovine spongiform encephalopathy (BSE), or mad cow disease, at a farm in Ardennes. The case was detected in a 5-year-old cow sent for rendering, “a method for processing animals that die on farms, and are therefore not intended for human consumption,” states AFP. In France, the last case of bovine spongiform encephalopathy dates back to 2011.
-
What's on? - 24.03.2016
Isolated case of bovine spongiform encephalopathy (BSE) in France
This Thursday, 24 March, the Ministry of Agriculture confirmed an isolated case of bovine spongiform encephalopathy (BSE), or mad cow disease, at a farm in Ardennes. The case was detected in a 5-year-old cow sent for rendering, “a method for processing animals that die on farms, and are therefore not intended for human consumption,” states […]